Background {#Sec1}
==========

Long-stay patients (LSPs) in intensive care units (ICUs) are generally accepted as being susceptible to higher mortality than short-stay patients (SSPs) \[[@CR1]\]. In addition, they consume a higher amount of medical costs, resources, and ICU capacity \[[@CR2]\]. Since the 1980s, when pediatric LSPs in ICUs first got attention in research \[[@CR3]\], the number of pediatric LSPs in ICUs has been increasing, with the development of life-supporting skills and technologies such as the availability of the pediatric advanced life support course or extracorporeal membrane oxygenation therapy \[[@CR4]\]. Multiple studies reported that they are responsible for more than one third of ICU bed days although the proportion of LSPs among the entire admitted population is smaller than 10% \[[@CR3], [@CR5]--[@CR7]\]. It is often the case for pediatric LSPs that their functional outcomes are unfavorable (moderate or severe disabilities, and death) \[[@CR8]\]. Although these basic data are essential for discussion to improve the current ICU practices for pediatric patients, Japan has little data about pediatric LSPs in the ICU.

Predicting LSPs in ICUs on admission has been another interest of research for decades \[[@CR6], [@CR9]--[@CR12]\]. Appropriate prediction might provide practical assistance for proactive patient management in ICUs \[[@CR11]\]. Health care teams could be dedicated to communicate and purvey sufficient information to families and clinicians could deliberately provide preventive care against different complications. ICU staff could systematically schedule bed use and medical resources. Experienced ICU staff might be able to predict pediatric LSPs on admission; however, this would be unreliable. In fact, clinicians could predict LSPs less correctly than SSPs in adult ICU settings \[[@CR13]\]. There have been several studies in the USA that attempted to develop predictive models for the length of stay (LOS) of pediatric patients in the ICU \[[@CR5], [@CR6]\]. However, it is easily assumed that these foreign models have limited applicability to pediatric populations in Japanese ICUs because of the wide differences in common diseases among children and health care systems \[[@CR14], [@CR15]\]. Moreover, the discussion regarding LSP prediction for pediatric patients in the ICU is still poor in Japanese ICUs.

The paucity of data prompted us to survey the pediatric LSP population in Japanese ICUs and to create a useful system to identify them in the early ICU course, using consecutive pediatric data (\< 16 years old) registered in the Japanese Registry of Pediatric Acute Care (JaRPAC).

Methods {#Sec2}
=======

JaRPAC overview {#Sec3}
---------------

JaRPAC is an observational, multicenter, prospective database that contains data on consecutive pediatric patients admitted to ICUs in Japan. The registry was started on October 1, 2013. The study is mainly led by the pediatric committee of the Japanese Society for Emergency Medicine and the study website can be reached at [jarpac.org.]{.ul} The JaRPAC registry includes information on admitted patients to ICU or those who died in the emergency room. The subjects in children's hospitals are all registered regardless of their age, while those in other hospitals are registered if their age is less than 16 years. Otherwise, no exclusion criteria are applied to the registry. Using application software designated for this database, patients' data are collected with 23 variables at admission and 27 variables at discharge from ICU, including data regarding pre-hospital management, the predictive death rate, demographics, treatments, and outcomes. The software equips automated logic checks to avoid miss-hit or data deficiencies. The registry is securely held at the National Center of Child Health and Development (NCCHD) and anonymized data are provided to the principal investigator on request with a specific study protocol that was approved by the JaRPAC steering committee. The study results are available to the public in the form of annual reports, conference abstracts, and peer-reviewed publications.

Patient data {#Sec4}
------------

We obtained the following 3 year JaRPAC data of consecutive patients aged less than 16 years who were admitted to ICU from October 2013 to September 2016 to survey the characteristics of pediatric LSPs in ICUs (analysis dataset): sex, age in month, dates of admission and discharge from the ICU, reasons for ICU admission, diagnosis at discharge, disease category, elective/emergency admission status, cardiopulmonary resuscitation (CPR) before admission or during the ICU stay, Pediatric Index of Mortality 2 (PIM2) \[[@CR16]\], chromosome abnormalities, discharge disposition, and Pediatric Cerebral Performance Category (PCPC) score \[[@CR17]\] before admission and at discharge from the ICU. The Injury Severity Score (ISS) \[[@CR18]\] was extracted for all patients with injuries. JaRPAC codes the reason for admission into seven categories: postoperative management, post CPR, respiratory distress, circulatory disorder, neurological disorders, monitoring/assessment, and others. Allowable values for discharge disposition in JaRPAC are defined within five categories: general ward, back transferred to the original hospital, transferred to another hospital, home, and expired. Furthermore, JaRPAC categorizes diseases in a three-step manner; an additional table file shows this in more details (see Additional file [1](#MOESM1){ref-type="media"}). PIM2 and PCPC scores are the fundamental tools used worldwide for the evaluation of pediatric patients in the ICUs. Briefly, PIM2, the calculation system for predicting mortality rates for pediatric patients, uses 10 variables. The PCPC score is a tool for quantifying short-term cognitive impairments in pediatric patients; it has a scale ranging from 1 to 6 (1 = normal, 2 = mild disability, 3 = moderate disability, 4 = severe disability, 5 = coma or vegetative state, and 6 = brain death).

It should be noted that although the JaRPAC registry includes information on patients who died in the emergency room, we excluded the data of these patients at the point of data extraction. Furthermore, we did not exclude any other patients while creating the prediction model for LSPs. This means that our analysis included data of patients who died within several days after ICU admission in SSPs because the clinicians could not predict whether patients would die at the point of their ICU admission.

In total, seven facilities registered their patients' data in the JaRPAC database during our study period. The characteristic breakdown of these facilities is as follows: (1) four pediatric ICUs (4--20 beds; a total of 38 beds) and (2) three general (mixed adult-pediatric) ICUs (12--20 beds; a total of 52 beds). There were no ICUs classified as "cardiac ICUs."

We obtained the same JaRPAC data as described above from the same facilities included in the original dataset for consecutive patients (\< 16 years) from October 2016 to September 2017 to test the accuracy of prediction for the newly developed score as we shall explain later; these data represented the "internal" validation dataset. In addition, we obtained the same data from facilities newly joined during this period (not included in the original dataset, one general PICU \[10 beds\] and one general adult-mixed ICU \[8 beds\]); these data represented the "external" validation dataset.

Defining the LSPs {#Sec5}
-----------------

LOS was calculated by subtracting the date of ICU admission from the date of ICU discharge plus one. The definition of LSP was determined considering various indexes by following the techniques described in similar studies \[[@CR19], [@CR20]\]: (1) beyond five times the median LOS, (2) beyond the 95th percentile of the LOS, (3) greater than two standard deviations from the mean in Gaussian distribution, and (4) beyond the visually recognized threshold from the "tail" portion of the LOS histogram in the case of skewed distribution.

Statistical analysis {#Sec6}
--------------------

After we examined the distribution of LOS in ICUs to define the LSP, we conducted a descriptive analysis of the participants overall or stratified by the LSP status. We then compared the risk of mortality (i.e., expired) obtained from the discharge disposition as clinical outcomes between LSPs and SSPs. We also calculated the rate of mortality considering the patient-day as a denominator, stratified by the LOS.

We then created a prediction model for LSPs. We conducted a backward selection stepwise logistic regression model and used the significance level of *p* = 0.05 for removal of variables from the model. When a least-significant variable was non-significant, the variable was removed and the model was re-estimated; the final model was developed when all of the variables were significant. We entered the following variables in the model in the beginning: age (dichotomous, \< 2 years or ≥ 2 years); emergency admission (dichotomous); post CPR admission (dichotomous); admission due to circulatory disorders (dichotomous); disease category of myocarditis, congenital heart disease, encephalopathy/encephalitis, liver dysfunction, lung tissue disorders, or multiple trauma; PIM2 (dichotomous, \< 1 or ≥ 1); PCPC score on admission (dichotomous, \< 2 or ≥ 2); or ISS (dichotomous, \< 10 or ≥ 10). We selected the two reasons for admission and six disease categories because they predicted the LSPs based on the descriptive analysis. We then removed sex and chromosome abnormalities because the validation dataset did not include these variables. After selecting variables using a logistic regression model, we estimated odds ratios (ORs) with 95% confidence intervals (CIs) for each of the remaining variables and computed the area under the receiver operating characteristic (ROC) curve (AUC). To increase the usefulness of the prediction model, we assigned integer score points to each remaining variable based on the ORs and created a prediction rule for the LSPs, that assigned the defined integer score points based on the presence of each variable for the patients. We calculated the sum of all points for each patient in the current dataset, as well as, the validation dataset and again calculated the AUC. We also calculated the sensitivity and specificity of the prediction rule after defining the certain cutoff value based on the ROC curve.

Stata SE version 15 (StataCorp, College Station, TX, USA) was used for all analyses. This study was approved by the Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Institutional Review Board (Eki853 and Ken1812-027).

Results {#Sec7}
=======

There were 4108 ICU admissions during the 3 year study period included in the analysis dataset. Of these admissions, just one case was excluded because the dates of admission and discharge were obviously incorrect. Thereafter, the data for 4107 patients were used as the final analysis dataset.

LSP definition {#Sec8}
--------------

Figure [1](#Fig1){ref-type="fig"} portrays the frequency distribution of patients based on the length of stay in the ICU. The median and mean LOS were 3.0 (minimum to maximum, 1--370) and 6.2 ± 11.7 days, respectively. Considering its rightward skewed distribution, we calculated or visually identified three indexes described above to decide upon the clinical threshold for prolonged ICU stays: (1) 15 days for five times the median LOS, (2) 19 days as the 95th percentile of LOS, and (3) 13 days as the start of the "tail" of the distribution shown in Fig [1](#Fig1){ref-type="fig"}. Taken together these results, for the purpose of practical convenience, we defined LSPs as patients who had a LOS in the ICU greater than 14 days.Fig. 1Distribution of pediatric length of stay in intensive care units. Forty data points (91 patients) are outside the *x*-axis limits

Characteristics of the study population on admission {#Sec9}
----------------------------------------------------

Table [1](#Tab1){ref-type="table"} shows the patients' characteristics on admission. Overall, 42.9% (*n* = 1762) of patients were less than 2 years old and the majority of patients had emergency admissions (55.4%, *n* = 2277). Postoperative management was the most common reason for the ICU admission (44.2%, *n* = 1814). Most patients had an endogenous disease (91.6%, *n* = 3760) and had a good functional status before ICU admission (76.4%, *n* = 3136, PCPC 1 and 2). Chromosomal abnormality was reported among 6.4% (*n* = 263) of patients, 59.7% (*n* = 157) of whom were 21 trisomy.Table 1Characteristics of pediatric patients on admission in Japanese intensive care unitsAll patients\
*n* = 4107SSPs\
*n* = 3777LSPs\
*n* = 330Sex- and age-adjusted OR of LSPs compared to SSPs (95% CI)Sex- and age-adjusted regression coefficient (95% CI)Age (month), median (IQR)23.0 (7.0--71.0)24.0 (8.0--71.5)10.0 (3.0--53.3)Male \[numbers (%)\]2362(57.5%)2165(57.3%)197(59.7%)Emergency admission \[numbers (%)\]2277(55.4%)2042(54.1%)235(71.2%)2.38(1.83--3.08)\*2.39(1.66--3.11)\*Reasons for admission \[numbers (%)\] Post-operative1814(44.2%)1730(45.8%)84(25.5%)1(Reference)(Reference) Post-CPR84(2.0%)59(1.6%)25(7.6%)9.29(5.51--15.65)7.53(5.00--10.07) Respiratory disorders833(20.3%)763(20.2%)70(21.2%)1.88(1.35--2.61)1.82(0.87--2.77) Circulatory disorders243(5.9%)193(5.1%)50(15.2%)5.23(3.57--7.67)4.12(2.57--5.67) Neurological disorders626(15.2%)578(15.3%)48(14.5%)1.80(1.25--2.61)1.86(0.80--2.91) Others507(12.3%)454(12.0%)53(16.1%)2.58(1.80--3.70)2.06(0.92--3.20)Diagnosis at admission \[numbers (%)\] CHD (all)523(12.7%)469(12.4%)54(16.4%)1.22(0.89--1.67)\*\*1.75(0.66--2.84)\*\*  Post-operation470(11.4%)431(11.4%)39(11.8%)0.92(0.65--1.32)\*\*1.26(0.12--2.40)\*\*  Non-post operation53(1.3%)38(1.0%)15(4.5%)3.92(2.12--7.25)\*\*5.02(1.86--8.20)\*\* Myocarditis/cardiomyopathy52(1.3%)34(0.9%)18(5.5%)6.16(3.43--11.08)\*\*6.85(3.67--10.03)\*\* Encephalitis/encephalopathy135(3.3%)110(2.9%)25(7.6%)2.84(1.81--4.47)\*\*7.98(6.00--9.97)\*\* Liver dysfunction (all)212(5.2%)155(4.1%)57(17.3%)4.72(3.39--6.56)\*\*6.28(4.68--7.88)\*\*  Post-transplantation97(2.4%)72(1.9%)25(7.6%)4.07(2.54--6.53)\*\*7.45(5.11--9.79)\*\*  Post-status of the other operation29(0.7%)29(0.8%)0(0%)1.00− 3.28(− 7.01 to 0.44)\*\*  Non post-operation77(1.9%)45(1.2%)32(9.7%)8.63(5.39--13.84)\*\*8.98(6.36--11.59)\*\* Upper airway obstruction198(4.8%)184(4.9%)14(4.2%)0.86(0.49--1.50)\*\*− 1.32(−2.98 to 0.35)\*\* Lower airway obstruction236(5.7%)230(6.1%)6(1.8%)0.28(0.12--0.63)\*\*− 0.29(− 1.82 to 1.25)\*\* Lung tissue disease241(5.9%)211(5.6%)30(9.1%)1.74(1.16--2.61)\*\*1.89(0.38--3.41)\*\* Disordered control of breathing48(1.2%)44(1.2%)4(1.2%)0.96(0.34--2.70)\*\*0.01(− 3.31 to 3.33)\*\* Trauma226(5.5%)218(5.8%)8(2.4%)0.45(0.22--0.92)\*\*− 1.91(− 3.49 to − 0.35)\*\*  Head injury132(3.2%)126(3.3%)6(1.8%)0.54(0.23--1.23)\*\*− 1.97(− 3.99 to 0.05)\*\* Multiple injury25(0.6%)23(0.6%)2(0.6%)1.20(0.28--5.14)\*\*− 0.18(− 4.78 to 4.42)\*\*ISS, median (IQR)10 (4--17)10 (4--17)17 (10--40)1.04(1.01--1.07)0.19(0.16--0.22)Per 1.0 increasePer 1.0 increasePIM2, median (IQR)1.0 (0.3--3.0)0.9 (0.2--2.2)5.3 (2.1--19.5)1.04(1.04--1.05)0.17(0.13--0.21)Per 1.0 increasePer 1.0 increasePCPC before admission \[Numbers (%)\]12733(66.5%)2515(66.6%)218(66.1%)1(Reference)(Reference)2403(9.8%)367(9.7%)36(10.9%)1.17(0.81--1.70)− 0.33(− 1.55 to 0.89)3423(10.3%)392(10.4%)31(9.4%)0.91(0.62--1.35)− 0.4(− 1.59 to 0.80)4537(13.1%)494(13.1%)43(13.0%)1.12(0.79--1.59)− 0.3(− 1.38 to 0.79)511(0.3%)9(0.2%)2(0.6%)2.95(0.63--13.84)13.43(6.54--20.33)Chromosomal abnormality \[Numbers (%)\]None(Reference)(Reference)21 trisomy157(3.8%)147(3.9%)10(3.0%)0.72(0.37--1.39)− 0.67(− 2.55 to 1.20)Others106(2.6%)92(2.4%)14(4.2%)1.77(0.99--3.15)1.00(− 1.27 to 3.26)*CHD* congenital heart disease, *CI* confidence interval, *CPR* cardio-pulmonary resuscitation, *IQR* interquartile range, *ISS* Injury Severity Score, *LSPs* long-stay patients, *NE* not examined, *OR* odd ratio, *PCPC* Pediatric Cerebral Performance Category, *PIM2* Pediatric Index of Mortality 2, *SSPs* short-stay patients\*The reference is the planned admission\*\*The reference is the other diagnoses

LSPs accounted for 8.0% (*n* = 330) of all patients. The proportion of LSP patients who were less than 2-years old was even greater than that of SSPs (60.9% versus 41.3%). The admission reasons of post-CPR and circulatory disorders were more common in LSPs. In terms of diagnosis, those with liver dysfunction, myocarditis/cardiomyopathy, CHD, encephalitis/encephalopathy, and lung tissue disease (pneumonia) were more likely to be LSPs. There was no correlation between PCPC before admission and LOS.

Clinical outcomes {#Sec10}
-----------------

Table [2](#Tab2){ref-type="table"} summarizes the clinical outcomes of the study population. LSPs consumed 38.0% of the ICU bed days. Mortality was seven times higher in LSPs than SSPs. Additionally, mortality during the first 0--14 ICU admission days was 0.0024/patient-days, while mortality after 14 ICU admission days was 0.0058/patient-days. Thus, if a patient stayed in the ICU for more than 14 days, mortality per day would increase by approximately 2.5 times that of a patient who stayed in the ICU for 14 days or less. After discharge from the ICU, most patients were managed in the same hospital as the ICU.Table 2Clinical outcomes of pediatric patients in intensive care units in JapanAll Patients\
*n* = 4107SSPs\
*n* = 3777LSPs\
*n* = 330Length of stay (days) Average (SD)6.2 (11.7)4.2 (2.9)29.6 (31.8) Median (IQR)3.0 (2.0--7.0)3.0 (2.0--6.0)21.0 (17.0--31.0)ICU bed days \[numbers (% total)\]2565915909 (62.0%)9750 (38.0%)Mortality \[numbers (%)\]79(1.9%)49(1.3%)30(9.1%)Discharge route \[numbers (%)\] General ward3649(88.8%)3390(89.8%)259(78.5%) Transfer to original hospital116(2.8%)90(2.4%)26(7.9%) Transfer to new hospital51(1.2%)40(1.1%)11(3.3%) Home212(5.2%)208(5.5%)4(1.2%)PCPC on discharge \[numbers (%)\] 12572(62.6%)2418(64.0%)154(46.7%) 2426(10.4%)395(10.5%)31(9.4%) 3435(10.6%)402(10.6%)33(10.0%) 4557(13.6%)498(13.2%)59(17.9%) 532(0.8%)14(0.4%)18(5.5%) 685(2.1%)50(1.3%)35(10.6%)Delta PCPC\* \[numbers (%)\] 03871(94.3%)3633(96.2%)238(72.1%) 166(1.6%)52(1.4%)14(4.2%) 248(1.2%)29(0.8%)19(5.8%) 338(0.9%)17(0.5%)21(6.4%) 428(0.7%)9(0.2%)19(5.8%) 548(1.2%)29(0.8%)19(5.8%) Unknown8(0.2%)8(0.2%)0(0)\*PCPC on discharge -- PCPC before admission*IQR* interquartile range, *LSPs* long-stay patients, *PCPC* Pediatric Cerebral Performance Category, *SD* standard deviation, *SSPs* short-stay patients

Predictive model for LSPs on admission {#Sec11}
--------------------------------------

In the first stepwise logistic regression model, all the remaining variables had ORs more than one as expected from the descriptive analysis, so we accepted the model. The AUC was 0.82 and we showed the remaining variables in Table [3](#Tab3){ref-type="table"}. As liver dysfunction (non-post operation) and PIM2 (≥ 1) had ORs of more than 5, we assigned a score of 2 to the variables and a score of 1 to the other variables. Thus, we ascertained the following prediction rule for LSPs.$$\documentclass[12pt]{minimal}
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                \begin{document}$$ \mathrm{Predictivescore}=\mathrm{PIM}2\left(\ge 1\right)\times 2+\mathrm{liverdysfunction}\left(\mathrm{non}-\mathrm{postoperation}\right)\times 2+\mathrm{postCPR}\times 1+\mathrm{circulatorydisorder}\times 1+\mathrm{liverdysfunction}\left(\mathrm{post}-\mathrm{operativemanagementoflivertransplantation}\right)\times 1+\mathrm{encephalitis}/\mathrm{encephalopathy}\times 1+\mathrm{myocarditis}/\mathrm{cardiomyopathy}\times 1+\mathrm{CHD}\left(\mathrm{non}-\mathrm{postoperation}\right)\times 1+\mathrm{lungtissuedisease}\times 1+\mathrm{PCPCbeforeadmission}\left(\ge 2\right)\times 1+\mathrm{age}\left(<2\mathrm{years}\right)\times 1 $$\end{document}$$Table 3Predictive Score for pediatric long-stay patients (score ≥ 3)Odds ratio(95% CI)ScoreReasons for admission Post CPR4.60(2.75--7.68)1 Circulatory disorder2.11(1.34--3.31)1Disease category Liver dysfunction (non-post operation)9.24(5.55--15.38)2 Post-operative management of liver transplantation4.31(2.58--7.20)1 Myocarditis/cardiomyopathy3.15(1.57--6.34)1 Encephalitis/encephalopathy3.16(1.95--5.13)1 CHD (non-post operation)2.44(1.18--5.04)1 Lung tissue disease (pneumonia)1.80(1.15--2.80)1Other factors PIM2 ≥ 110.97(6.62--18.19)2 Age \< 2 years1.60(1.23--2.08)1 PCPC ≥2 before admission1.36(1.03--1.79)1*CHD* congenital heart disease, *CI* confidence interval, *CPR* cardio-pulmonary resuscitation, *PCPC* Pediatric Cerebral Performance Category, *PIM2* Pediatric Index of Mortality 2

After we applied the prediction rule to the patients in the current dataset, the AUC was 0.79. When we used the cutoff point of 3 based on the ROC curve, the sensitivity and specificity for the LSPs were 87.0% and 59.4%, respectively. When we applied the prediction rule to the "internal" validation dataset (*n* = 378), the AUC was 0.80 and the sensitivity and specificity of LSPs were 92.6% and 60.2%, respectively, using the same cutoff point. Furthermore, when we applied the prediction rule to the "external" validation dataset (*n* = 295), the AUC was 0.76 and the sensitivity and specificity of LSPs were 91.7% and 53.9%, respectively, using the same cutoff point.

As the OR of PIM2 (≥ 1) was relatively higher than that of any other variables, we examined the predictive ability of PIM2 by itself for LSPs. PIM2 and patients' LOS had a negligible correlation (*r* = 0.20, Additional file [2](#MOESM2){ref-type="media"}). Moreover, the AUC was 0.71 when we applied PIM2 as a prediction rule for LSPs; this was lower than that of our newly developed prediction rule.

Discussion {#Sec12}
==========

In this study, we have newly provided an overview of pediatric long-stay ICU patients in Japan using the JaRPAC, a nationwide and multicenter database. Additionally, we have provided a unique and simple predictive scoring system using available data at the point of ICU admission to prospectively identify pediatric LSP-candidates. We showed that pediatric LSPs have a significant presence in Japanese ICUs with high rates of bed utilization and mortality. Eight percent of the entire population used almost 40% of the bed days. Additionally, the mortality in pediatric LSPs was significantly higher. These data signify the need for further interventions for improved LSP outcomes. Thus, identifying LSP candidates on ICU admission will help clinicians to intervene with such patients in the early course of the ICU stay. Although there have been multiple studies which provided prediction models for pediatric LSPs, our newly developed prediction system is so practical that clinicians could identify pediatric LSP candidates by simply adding the scores assigned to the risk factors.

Table [4](#Tab4){ref-type="table"} provides a summary of previous studies conducted regarding pediatric LSPs in ICUs; a study with a specific condition (post-cardiac surgery) was excluded. All studies were based on pediatric ICUs, and most of them were single-center studies. Even though the definition of LSPs differed from study to study, in all the studies, LSPs were commonly described as occupying excessive ICU bed days (18.5--63%) despite their smaller population frequencies (1.0--7.3%). Moreover, the mortality among LSPs was higher than that among SSPs in all studies. Comparable results were obtained from our study, although in this study, data from multiple mixed adult-pediatric ICUs were included. The differences in outcomes between pediatric ICUs and mixed adult-pediatric ICUs should be investigated in further studies.Table 4Summary of the published studies on pediatric long-stay patientsStudyAuthor, yearCountryStudy periodNo. of ICUsICU characteristicsStudy populationExclusion criteria1Pollack et al., 1987 \[[@CR3]\]USA1981--2, 1984--51Multidisciplinary PICUs647NA2Marcin et al., 2001 \[[@CR6]\]USANA32General PICUs11,165NA3van der Heide et al., 2004 \[[@CR10]\]Netherlands1992--19971Multidisciplinary PICUs34Age \< 1 year old, \>18 years old4Naghib et al., 2010 \[[@CR7]\]Netherlands2003--20051Multidisciplinary PICUs2607None5Namachivayam et al., 2012 \[[@CR8]\]Australia1989--20081Tertiary PICUs27,536NA6Nupen et al., 2017 \[[@CR17]\]South AfricaNA1Multidisciplinary PICUs1126NA7Pollack et al., 2018 \[[@CR5]\]USA2011--20138General and cardiac PICUs10,078Age \> 18 years old8Knaup et al., 2019Japan2013--20167General PICUs and mixed adult-pediatric ICUs4107Age \> 16 years oldStudyLSP definitionLSP numberLSP ageLOS of LSPs (days)Bed occupancy by LSPsMortality (SSPs/LSPs)1\> 13 days7.1% (*n* = 46)13 months\*35.8\*\*50.0%7.3%/17.4%2\> 12 days4.7% (*n* = 460)45.5 months^\*^28.3\*36.1%4.4%/15.0%3≥ 30 daysNA (*n* = 19)10.7 years\*\*37\*\*NANA/10.5%4≥ 28 days4.4% (*n* = 116)1 month\*\*56\*63.0%4.6%/22.0%5≥ 28 days1.0% (*n* = 269)4.2 months^\*^40\*18.5%NA6\> 19 days4.8% (*n* = 54)4.0 months\*29.5\*30.4%2.4%/29.6%7≥ 19 days4.6%NANA37.6%NA8\> 14 days8.0% (*n* = 330)10 months\*21\*38.0%1.3%/9.1%\*Median\*\*Mean*ICU* intensive care unit, *LOS* length of stay, *LSP*(*s*) long-stay patient(s), *NA* not available, *SSPs* short-stay patients, *USA* the United States of America

Table [5](#Tab5){ref-type="table"} summarizes the predictors of LSP or independent LSP-associated factors based on the findings of previous studies. Our study and previous studies include similar LSP predictors or LSP-associated factors including pneumonia \[[@CR6]\] (i.e., lung tissue disease) and the existence of underlying diseases \[[@CR5], [@CR6]\] (e.g., chronic total parenteral nutrition, tracheostomy, intracranial catheter, and higher PCPC). Intriguingly, our study showed post-CPR status as one of the LSP predictors, whereas no CPR-need prior to admission was identified as an LSP predictor in an American study \[[@CR6]\]. This might have been caused by the relatively low acceptance of treatment withdrawal in Japan. The mortality in pediatric ICUs after out-of-hospital cardiac arrest (OHCA) was reported to be as high as 45--50% in Western countries \[[@CR21], [@CR22]\], whereas this was as low as 34.1% based on our data, as shown in Additional file [3](#MOESM3){ref-type="media"}. Conversely, remarkably high rates of poor neurological outcomes at ICU discharge (PCPC = 4 or 5) in LSPs were seen in our analysis (Additional file [3](#MOESM3){ref-type="media"}). A study from a single center in the USA showed that 81% of the modes of death after pediatric OHCA were classified as brain death or withdrawal due to neurological prognosis after a median ICU admission of 4 days \[[@CR22]\]. Given the fact that the guidelines for treatment withdrawal have only recently been published in Japan \[[@CR23]\], it is a stretch to assume that the choice to withdraw from treatment for pediatric patients has been widely accepted in daily ICU management in Japan. However, further validations are required to corroborate this hypothesis.Table 5Predictors of long-stay pediatric patients or independent long-stay patient-associated factorsStudy\*Factors2 \[[@CR6]\]• Age \< 12 months• Previous ICU admission• Emergency admission• No CPR before admission• Pneumonia• Chronic TPN• Chronic tracheostomy• Admission from another ICU• Other respiratory diseases• Never discharged from the hospital• Ventilator• Intracranial catheter• 10 \< PRISM III---24 score \< 336 \[[@CR17]\]• Female gender7 \[[@CR5]\]• Age \< 12 months• Moderate or severe baseline FFS• PRISM III total score• ECMO during PICU stay• RRT during PICU stay• MV during PICU stay• Vasoactive infusions during PICU stay• Antibiotics during PICU stay• Neuromuscular blockade during PICU stay• Steroids use during PICU stay8• Age \< 2 years• Post CPR• Circulatory disorder• Myocarditis/cardiomyopathy• PCPC ≥ 2 before admission• Encephalitis/encephalopathy• Liver dysfunction\*\*• CHD (non-post-operative)• Lung tissue disease (pneumonia)• PIM2 ≥ 1\*Study numbers are consistent with those in Table [4](#Tab4){ref-type="table"}\*\*Status for non-post operation or post-liver transplantation*CHD* congenital heart disease, *CPR* cardiopulmonary resuscitation, *ECMO* extracorporeal membrane oxygenation, *FFS* Functional Status Scale, *ISS* Injury Severity Score, *MV* mechanical ventilation, *PCPC* Pediatric Cerebral Performance Category, (*P*)*ICU* (pediatric) intensive care unit, *PIM2* Pediatric Index of Mortality 2, *PRISM* Pediatric Risk of Mortality, *RRT* Renal replacement therapy, *TPN* total parenteral nutrition

We also found that LSPs were significantly younger and were likely to be admitted with an emergency status including post-CPR or circulatory disorders when compared with SSPs. Additionally, LSPs were more likely to have a higher predicted mortality (PIM2). Thus, it is not surprising that these factors were reflected as items in our developed predictive scoring system. In particular, the predictive mortality rate seemed to have significance for LSP prediction, which was assigned 2 points in the scoring system. There may be a reason in the computation method of predictive mortality using PIM2. PIM2 is calculated based on multiple indices such as (1) mechanical ventilation at any time during the first hour in the ICU, (2) emergency admission, (3) admission for recovery from surgery or a procedure, (4) admission following cardiac bypass, and (5) cardiac arrest preceding admission. These indicators have been known to be involved in the patients' LOS in the ICU \[[@CR6], [@CR24]--[@CR26]\]. Accordingly, PIM2 naturally seems to have been chosen as a significant predictive factor; however, our study showed that our newly developed rule performed better than PIM2 by itself to predict LSPs upon admission. Thus, it could be inferred that our predictive model was a result of correct weighting of PIM2 using additional factors listed on Table [3](#Tab3){ref-type="table"}.

Liver dysfunction for non-operative management, myocarditis/cardiomyopathy, and encephalopathy/encephalitis are the curious indices in our predictive LSP score. We speculate that these factors have significance in LSPs because of their unique treatment modality features.Liver dysfunction for non-operative managementAcute liver failure in patients who need direct ICU management (i.e., the primary reason for ICU admission was not for post-operative management) could be severe because of fulminant hepatic failure, thus requiring aggressive blood-purification \[[@CR7]\]. Moreover, a large number of these patients would require liver transplantation \[[@CR27]\], resulting in a longer ICU stay as shown in Additional file [4](#MOESM4){ref-type="media"}. There are very few brain-dead donor livers available in Japan; thus, this might contribute to longer waiting times causing prolonged ICU admissions \[[@CR28]\].Myocarditis/cardiomyopathyIt is well known that there is a wide range of disease severities in this disease category. Mechanical circulatory support (MCS) with extracorporeal membrane oxygenation (ECMO) among rapidly deteriorating patients can be imperative for recovery or might act as a bridge to probable heart transplantation. The number of myocarditis patients who undergo MCS has been increasing in Japan \[[@CR29]\], placing an additional demand on ICUs for this population. ECMO use during PICU stay has been reported as a factor associated with LSP \[[@CR5]\]. A report from a single Japanese center described that myocarditis patients underwent ECMO therapy for median 6 days when ECMO was implemented \[[@CR30]\], which is comparative with the findings in this study (Additional file [5](#MOESM5){ref-type="media"}).Encephalitis/encephalopathyEncephalitis/encephalopathy should influence LOS as a result of its neurological impairment with different ranges as well as the need for treatment using hypothermia therapy \[[@CR31]--[@CR33]\]. Suggested hypothermia protocols require approximately 5 days to complete \[[@CR32], [@CR33]\]. One case series from a single Japanese ICU reported that these patients underwent mechanical ventilation for 9.4 days on an average \[[@CR33]\]. The use of neuromuscular blockade for temperature control can also influence LOS \[[@CR5]\]. The frequent prevalence of encephalitis/encephalopathy in East Asia may involve the statistical significance in our study in Japan \[[@CR34]\].

Overall, these unique treatment modalities still need to be validated for their efficacy, despite their practice in some ICUs in Japan. Thus, the management of these diseases would be expected to change due to further research developments.

It is intriguing that our LSP predictive score contains the patients' status post-liver transplantation. It seems that their LOS depends on their number of ventilation days (Additional file [6](#MOESM6){ref-type="media"}). A previous study reported that prolonged mechanical ventilation in pediatric liver transplant recipients had longer ICU LOS, which was associated with younger patient age, preoperative hypocalcemia, and increasing duration of surgery \[[@CR35]\]. The addition of this clinical information might improve the specificity of the current LSP predictive score in future studies.

The definition for LOS has been an important discussion point for a long time in the research on LSPs. Previous studies employed different cutoffs ranging from 2 to 30 ICU days. In this study, we attempted to define LSPs using an acceptable approach for everyone \[[@CR19]\] and employed a cutoff of 14 ICU days. Eventually, the cutoff point coincided with the maximum number of days that hospitals are allowed to charge for pediatric ICU management according to the 2019 Japanese health insurance system. Thus, our cutoff makes the study more practical for Japanese ICUs.

This study was inherently subject to some other limitations. First, institutional factors, such as the differences in practice, capacity, or patient populations, could not be accounted for in our extracted data. These factors may influence patients' LOS because the discharge criteria from ICU may vary among facilities. Furthermore, the decision to discharge a patient may not always be based on the criteria; sometimes it is influenced by bed-control matters throughout the hospital or the regional regulation among related hospitals. Thus, the LOS in ICUs may not always precisely indicate the patients' clinical needs. Second, two variables (sex and chromosomal abnormality) that seemed significant for the prediction of LSPs were unavailable in our validation dataset due to the revision of registration templates during our study period. There might be other factors that were not included in the JaRPAC database that could have predicted a long stay in ICU better. Additionally, the stepwise variable selection we performed in our analysis does not necessarily assure us of the independence of the variables selected in the model. However, as expected, all the remaining variables had ORs of more than one based on descriptive analysis, suggesting limited concerns regarding multicollinearity. Third, the size of our validation dataset was relatively small. Additional verification studies are warranted using external databases or prospectively accumulated datasets in daily ICU settings. Fourth, descriptive patient factors on ICU admission might be statistically important but insufficient to predict the LOS of each patient \[[@CR5]\]. Our newly developed LSP predictive score has high sensitivity with low specificity. As LOS prediction aims primarily to improve outcomes for patients and their families, high sensitivity of LSP prediction is required. Conversely, low specificity might hinder the reduction of medical costs and the utilization of resources. Analysis of the association between patients' outcomes and medical costs or resource consumption in LSPs is warranted in future studies. Fifth, the JaRPAC's disease categories are registered based on the primary target disease upon admission, which suggest that our analysis might overlook the accompanied conditions (e.g., shock \[circulatory disorder\] with encephalitis/encephalopathy). Therefore, these viewpoints should be included in future verification studies. Additionally, technological and scientific innovations in ICU treatment could shorten the LOS. Thus, regular revisions would be necessary to accurately reflect the pediatric LSP population.

Conclusions {#Sec13}
===========

Despite being a demographic minority, pediatric LSPs had high rates of bed utilization and mortality in Japanese ICUs. Our newly developed predictive scoring system may help to identify pediatric LSPs upon admission.

Additional files
================
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Additional file 1:Japanese Registry of Pediatric Acute Care Disease Category. (DOCX 20 kb) Additional file 2:Distribution of PIM2 against patients' length of stay (LOS). PIM2 has a negligible correlation with patients' LOS in the entire study population (*r* = 0.20). Dotted line indicates 15 days of LOS. Each red plot indicates a dead subject. Seven data points are outside the *x*-axis limits. (PPTX 455 kb) Additional file 3:Clinical outcomes of pediatric patients in Japanese intensive care units admitted with post-out-of-hospital cardiac pulmonary resuscitation status. (DOCX 16 kb) Additional file 4:Clinical outcomes of pediatric patients in Japanese intensive care units admitted for non-postoperative management of liver dysfunction. (DOCX 17 kb) Additional file 5:Clinical outcomes of pediatric patients in Japanese intensive care units with the diagnosis of myocarditis/cardiomyopathy. (DOCX 17 kb) Additional file 6:Clinical outcomes of pediatric patients in Japanese intensive care units primarily admitted for postoperative management of liver transplantation. (DOCX 21 kb)
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:   Mechanical circulatory support
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